Buscar
Congreso SOLACI

Búsqueda de: arterial hypertension

Si no está conforme con los resultados, inténtelo de nuevamente.
Other

Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

Pulmonary vessels are densely innervated by sympathetic, parasympathetic, and sensitive fibers.  According to the World Health Organization (WHO)...
solaci -
Ir
Day 2

Epidemiologic Characteristics of Arterial Hypertension in Latin American Countries

Jorge Oseguera Moguel 2012-08-09
solaci -
Ir
Interventional Cardiologists

Riociguat, a new drug for pulmonary arterial hypertension

Título original: Riociguat for the Treatment of Pulmonary Arterial Hypertension. Referencia: Hossein-Ardeschir Ghofrani et al. N Engl J Med 2013;369:330-40.  Many...
solaci -
Ir
Other

TCT 2022 | Pulmonary Artery Denervation in Primary Pulmonary Hypertension

Primary Pulmonary Hypertension is behind multiple hospitalizations and pulmonary transplants. Even though its treatment has been advanced,...
solaci -
Ir
HIGHLIGHTS

TCT 2018 | PADN-5: Pulmonary Artery Denervation in Pre- and Post-Capillary Pulmonary Hypertension

This work included 98 patients with pre- and post-capillary pulmonary hypertension defined as mean pulmonary arterial pressures ≥25 mmHg,...
solaci -
Ir
Other

New European Hypertension Guidelines Contrast with American Recommendations

The European guidelines on hypertension have been updated and now feature differences compared with American guidelines regarding...
solaci -
Ir
Other

Balloon Angioplasty: A Reasonable Plan B for Chronic Thromboembolic Hypertension

Thromboembolic pulmonary hypertension is caused by pulmonary artery stenosis caused by organized thrombi. The only treatment potentially healing for...
solaci -
Ir
Other

Hemodynamic, Functional and Clinical Response to Pulmonary Artery Denervation in Patients with Pulmonary Hypertension

Original Title: Hemodynamic. Functional and Clinical Responses to Pulmonary Artery Denervation with Pulmonary Artery Hypertension of Different...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad